GO:0052381 tRNA dimethylallyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0052381 describes the catalytic activity that transfers a dimethylallyl group from dimethylallyl diphosphate to adenosine at position 37 of tRNA, forming N6-dimethylallyladenosine (i6A).
• The enzyme is widely known as tRNA isopentenyltransferase (IPTase) and is encoded by MiaA in bacteria and by TRIT1 in humans [1,6].
• The modification occurs on tRNAs that read codons starting with uridine and is critical for efficient codon-anticodon pairing and translational fidelity [2,6].
• Bacterial MiaA is a well-studied model for substrate recognition, with the anticodon stem-loop being the major determinant for tRNA binding.
• Defects in tRNA modification can impact mitochondrial translation and have been linked to Perrault syndrome and other metabolic disorders.
• CRISPR-based knockout, point-mutation, and knock-in models are powerful tools to dissect the physiological roles of tRNA dimethylallyltransferase activity.
Description
tRNA dimethylallyltransferase activity (GO:0052381) is a molecular function that catalyzes the transfer of a dimethylallyl group from dimethylallyl diphosphate (DMAPP) to the adenosine at position 37 of certain tRNAs, producing N6-dimethylallyladenosine (i6A). This modification is one of the most conserved tRNA modifications and is found in bacteria, eukaryotes, and archaea. The enzyme responsible is known as tRNA isopentenyltransferase (IPTase) and is encoded by the miaA gene in Escherichia coli and by TRIT1 in humans [1,6]. The activity is essential for optimal codon-anticodon interactions, particularly for tRNAs that read codons beginning with uridine. Researchers study GO:0052381 because it sits at the intersection of translation, mitochondrial function, and human disease. The i6A modification enhances translational efficiency and fidelity, and its loss can lead to pleiotropic phenotypes including slow growth and respiratory defects in bacteria. In eukaryotes, the modification is critical for mitochondrial translation and for the synthesis of proteins containing noncanonical amino acids in engineered systems [4,7]. Understanding the molecular details of this activity provides insights into fundamental translation mechanisms and offers potential therapeutic targets for diseases linked to tRNA modification defects. This article integrates authoritative QuickGO data with verified PubMed literature to provide a comprehensive overview of the mechanism, key genes, disease associations, and research methods for studying tRNA dimethylallyltransferase activity.
tRNA dimethylallyltransferase activity At A Glance
| GO ID | GO:0052381 |
|---|---|
| GO term | tRNA dimethylallyltransferase activity |
| Ontology | molecular_function |
| Synonym | tRNA isopentenyltransferase activity; dimethylallyl-diphosphate:tRNA dimethylallyltransferase activity; tRNA N6-adenosine-37 dimethylallyltransferase activity; tRNA prenyltransferase activity |
| Major function | Catalyzes the transfer of a dimethylallyl group from DMAPP to adenosine 37 of tRNA, forming i6A |
| Reaction | adenosine(37) in tRNA + dimethylallyl diphosphate = N(6)-dimethylallyladenosine(37) in tRNA + diphosphate |
| Substrate | tRNA containing adenosine at position 37; dimethylallyl diphosphate (DMAPP) |
| Product | N6-dimethylallyladenosine (i6A) at position 37 in tRNA; diphosphate |
| Cellular location | Cytoplasm (bacteria); mitochondria and cytoplasm (eukaryotes) [6,7] |
What Is GO:0052381?
tRNA dimethylallyltransferase activity is defined by the Gene Ontology as the catalysis of the reaction: adenosine(37) in tRNA + dimethylallyl diphosphate = N(6)-dimethylallyladenosine(37) in tRNA + diphosphate [QuickGO]. In simpler terms, it is the enzyme activity that attaches a dimethylallyl group to a specific adenosine in tRNA, modifying the tRNA so it can function more efficiently in protein synthesis.
Why Is tRNA dimethylallyltransferase activity Important in Cell Biology?
tRNA dimethylallyltransferase activity is crucial for translational efficiency and fidelity because the i6A modification at position 37 stabilizes codon-anticodon interactions, particularly for tRNAs that read codons starting with uridine. In bacteria, loss of this activity leads to slow growth and defects in isoprene metabolism. In humans, mutations in the gene encoding this activity (TRIT1) have been associated with mitochondrial translation defects and Perrault syndrome, highlighting its clinical relevance. Furthermore, this activity is exploited in synthetic biology for the production of proteins containing noncanonical amino acids.
• Enhances translational fidelity by stabilizing codon-anticodon pairing for tRNAs reading UNN codons.
• Required for efficient mitochondrial translation in eukaryotes, impacting oxidative phosphorylation.
• Mutations in human TRIT1 are linked to Perrault syndrome and other metabolic disorders.
• Bacterial MiaA is a model system for studying enzyme-substrate recognition and catalysis [1,3].
• The i6A modification is essential for the production of proteins with noncanonical amino acids in engineered strains.
• Loss of activity leads to pleiotropic phenotypes including slow growth and respiratory defects.
• The enzyme is a potential target for antimicrobial drug development due to its essential role in bacteria.
• Understanding its mechanism aids in the design of tRNA-based therapeutics and synthetic biology tools.
Molecular Mechanism of tRNA dimethylallyltransferase activity
Substrate Recognition and Binding
In simple terms: The enzyme must first find and grab the correct tRNA molecule and the DMAPP molecule.
tRNA dimethylallyltransferase specifically recognizes tRNA substrates that have an adenosine at position 37 and a particular anticodon stem-loop structure. Studies on E. coli MiaA have shown that the anticodon stem-loop, especially the loop nucleotides, are essential for substrate recognition. The enzyme binds DMAPP in a pocket that coordinates the diphosphate group, and site-directed mutagenesis of highly conserved residues has identified key amino acids involved in DMAPP binding and catalysis. The binding mechanism involves conformational changes that bring the substrates into proximity for the transfer reaction.
Catalytic Transfer of the Dimethylallyl Group
In simple terms: The enzyme snips off the dimethylallyl part of DMAPP and attaches it to the adenosine in tRNA.
The catalytic mechanism involves the nucleophilic attack of the N6 amino group of adenosine 37 on the dimethylallyl moiety of DMAPP, displacing diphosphate. This reaction is thought to proceed through a transition state stabilized by conserved residues in the active site. The enzyme does not require metal ions for catalysis, and the reaction is reversible under certain conditions. The product, i6A, is a modified base that enhances base stacking and hydrogen bonding with the codon.
Enzyme Structure and Active Site Architecture
In simple terms: The enzyme has a specific shape with a pocket where the reaction happens.
tRNA dimethylallyltransferases belong to the aromatic prenyltransferase family and share a common fold with a central beta-sheet surrounded by alpha-helices. The active site is located in a deep cleft that accommodates both DMAPP and the adenosine 37 of tRNA. Crystal structures of related prenyltransferases have revealed a conserved DMAPP-binding motif and a positively charged surface for tRNA interaction. Mutagenesis studies have confirmed the roles of specific residues in substrate binding and catalysis.
Post-catalytic Release and tRNA Maturation
In simple terms: After the modification, the tRNA is released and can go on to participate in protein synthesis.
Following the transfer reaction, the modified tRNA is released from the enzyme. The i6A modification at position 37 is often further modified in some organisms (e.g., to ms2i6A in bacteria), but the initial dimethylallyl transfer is the first committed step. The modification enhances the tRNA's ability to interact with the ribosome and elongation factors, thereby promoting efficient translation. In eukaryotes, the modification is also important for mitochondrial tRNA function.
Key Genes Involved in GO:0052381 tRNA dimethylallyltransferase activity
The following genes and proteins are directly involved in or closely associated with tRNA dimethylallyltransferase activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MiaA (E. coli) | Encodes tRNA dimethylallyltransferase; catalyzes i6A formation | Model enzyme for substrate recognition and catalysis [1,2,3] |
| TRIT1 (human) | Human homolog of MiaA; mitochondrial and cytoplasmic tRNA modification | Mutations linked to Perrault syndrome and mitochondrial translation defects |
| tRNA genes (e.g., tRNA-Phe, tRNA-Ser) | Substrates for the enzyme; contain adenosine at position 37 | Used to study substrate specificity and modification effects |
| DMAPP synthase (e.g., IspA) | Produces DMAPP, the prenyl donor | Affects substrate availability for the modification |
| Ribosomal proteins | Facilitate translation of modified tRNAs | Downstream effectors of i6A function |
| Elongation factors (EF-Tu) | Interact with modified tRNAs during translation | Modification enhances EF-Tu binding |
| tRNA modification enzymes (e.g., TruA, TruB) | Other tRNA modifications that may interact with i6A | Potential epistatic effects |
| MiaB (E. coli) | Further modifies i6A to ms2i6A | Downstream modification in bacteria |
| TRIT1 variants | Human mutations associated with disease | Clinical relevance and genotype-phenotype studies |
| PEX6, CLPP, GGPS1, LARS2, TFAM | Genes implicated in Perrault syndrome with tRNA-related defects | Disease modeling and genetic interaction studies |
| Aromatic prenyltransferases (homologs) | Structural and mechanistic models | Comparative enzymology |
| tRNA isopentenyltransferases (eukaryotic) | Orthologs in yeast, plants, etc. | Evolutionary conservation and functional studies |
How Is tRNA dimethylallyltransferase activity Regulated?
The activity of tRNA dimethylallyltransferase is primarily regulated at the level of gene expression and substrate availability. In E. coli, MiaA expression is constitutive but can be influenced by growth conditions. The availability of DMAPP, which is derived from the mevalonate pathway, can affect the rate of modification. In eukaryotes, TRIT1 is expressed in multiple isoforms and its activity may be regulated by mitochondrial import and tRNA availability. There is limited evidence for direct post-translational regulation of the enzyme itself, but cellular stress conditions that affect tRNA integrity or DMAPP levels could indirectly modulate activity.
tRNA dimethylallyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRIT1 | Perrault syndrome; mitochondrial translation defect | Knockout or point-mutation in human cell lines; patient-derived fibroblasts |
| MiaA (E. coli) | Bacterial growth and isoprene metabolism | Knockout mutants in E. coli; growth assays |
| TRIT1 variants | Sensorineural hearing loss; ovarian dysgenesis | Knock-in mouse models; iPSC-derived organoids |
| tRNA genes | Translational fidelity and cancer | Overexpression of modified tRNAs in cancer cell lines |
| DMAPP pathway genes | Metabolic disorders | Knockout of IspA in bacteria; metabolic profiling |
Perrault Syndrome and Mitochondrial Translation Defects
Mutations in TRIT1, the human gene encoding tRNA dimethylallyltransferase, have been identified in patients with Perrault syndrome, a rare autosomal recessive disorder characterized by sensorineural hearing loss and ovarian dysgenesis. These mutations impair mitochondrial translation, leading to reduced oxidative phosphorylation and clinical symptoms. The study by Tucker et al. (2020) highlighted the diverse molecular causes of Perrault syndrome, including defects in tRNA modification enzymes like TRIT1.
Cancer and Metabolic Reprogramming
Altered tRNA modification patterns, including i6A levels, have been observed in various cancers, although direct links to tRNA dimethylallyltransferase activity are still emerging. The enzyme's role in translational efficiency may influence oncogenic pathways by modulating the translation of specific mRNAs. Further research is needed to establish causal relationships.
Bacterial Pathogenesis and Antimicrobial Targets
In pathogenic bacteria, MiaA is important for growth and virulence. Isoprene mutants of E. coli lacking miaA show slow growth and altered metabolism. This makes the enzyme a potential target for antimicrobial therapy, as inhibiting its activity could attenuate bacterial growth.
From tRNA dimethylallyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of MiaA knockout on bacterial growth? | E. coli miaA knockout strain |
| How do TRIT1 mutations affect mitochondrial translation? | Human TRIT1 knockout cell lines complemented with patient variants |
| What is the substrate specificity of tRNA dimethylallyltransferase? | In vitro assays with purified enzyme and mutant tRNAs |
| Can i6A modification be used to enhance noncanonical amino acid incorporation? | Engineered E. coli strains with heterologous tRNA modifications |
| What are the structural determinants of DMAPP binding? | Site-directed mutagenesis and crystallography of MiaA |
| How does i6A affect codon-anticodon pairing? | Ribosome profiling and biochemical assays |
How to Study the tRNA dimethylallyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro transferase assay | Enzyme activity using radiolabeled DMAPP | Kinetic studies and inhibitor screening |
| Ribosome profiling (Ribo-seq) | Translation efficiency and codon occupancy | Global effects of i6A on translation |
| LC-MS/MS | Levels of i6A and other tRNA modifications | Quantification of modification changes |
| CRISPR-Cas9 knockout | Loss-of-function phenotypes | Functional studies in cells and organisms |
| Site-directed mutagenesis | Identification of essential residues | Mechanistic studies of MiaA |
| Crystallography | Three-dimensional structure of enzyme-substrate complexes | Structural basis of catalysis |
| Northern blot | tRNA expression and modification status | Validation of tRNA substrates |
| Mitochondrial translation assays | Mitochondrial protein synthesis | Assessing TRIT1 function in mitochondria |
Biochemical Assays for Enzyme Activity
In vitro assays using purified enzyme and radiolabeled DMAPP can measure the transferase activity directly. These assays typically involve incubating the enzyme with tRNA substrate and DMAPP, followed by separation of products by HPLC or TLC. Such methods are essential for kinetic studies and inhibitor screening.
Ribosome Profiling and Translation Efficiency
Ribo-seq can be used to assess the impact of i6A modification on translation efficiency and fidelity. By comparing wild-type and mutant cells, researchers can identify codons that are particularly dependent on the modification. This method provides a global view of translational changes.
Mass Spectrometry for tRNA Modification Analysis
LC-MS/MS can quantify the levels of i6A and other modifications in tRNA isolated from cells. This approach is highly sensitive and can detect changes in modification stoichiometry under different conditions. It is useful for validating knockout or knockdown effects.
CRISPR-Cas9 Genome Editing for Functional Studies
CRISPR-Cas9 can be used to generate knockout, point-mutation, or knock-in models to study the physiological roles of tRNA dimethylallyltransferase. For example, knockout of TRIT1 in human cells can reveal its role in mitochondrial translation. These models are invaluable for linking genotype to phenotype.
How CRISPR Can Be Used to Study GO:0052381 tRNA dimethylallyltransferase activity
Knockout
CRISPR-Cas9 knockout of MiaA in E. coli or TRIT1 in human cells can abolish tRNA dimethylallyltransferase activity, leading to loss of i6A modification. This results in growth defects in bacteria and mitochondrial translation impairment in human cells [7,8]. Knockout models are essential for understanding the physiological consequences of the modification.
Point Mutation
Introducing specific point mutations in the catalytic residues of MiaA or TRIT1 can dissect the mechanism of catalysis and substrate binding. For example, mutations in conserved residues identified by site-directed mutagenesis can be recapitulated using CRISPR to study their effects in vivo.
Knock-in
Knock-in of patient-derived TRIT1 variants into a safe harbor locus or the endogenous locus can model Perrault syndrome and other diseases. This allows researchers to study the impact of specific mutations on mitochondrial function and tRNA modification.
Overexpression
Overexpression of tRNA dimethylallyltransferase can be achieved by CRISPR activation or by introducing a constitutive promoter. This is useful for producing high levels of modified tRNA for structural or biochemical studies, and for enhancing noncanonical amino acid incorporation in synthetic biology.
How EDITGENE Supports tRNA dimethylallyltransferase activity Research
Researchers studying tRNA dimethylallyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as mitochondrial translation defects or bacterial growth. This requires precise genome editing tools to create knockout, point-mutation, knock-in, or overexpression models. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such investigations.
Contact EDITGENE today to design your custom CRISPR model for tRNA dimethylallyltransferase activity research.
Frequently Asked Questions About tRNA dimethylallyltransferase activity
What is tRNA dimethylallyltransferase activity?
It is the enzyme activity that transfers a dimethylallyl group from DMAPP to adenosine 37 of tRNA, forming i6A, as defined by GO:0052381.
What genes are involved in tRNA dimethylallyltransferase activity?
The main genes are MiaA in bacteria and TRIT1 in humans, which encode the enzyme [1,6].
What is the role of i6A modification in translation?
i6A at position 37 stabilizes codon-anticodon interactions, enhancing translational fidelity and efficiency, especially for tRNAs reading UNN codons.
How is tRNA dimethylallyltransferase activity studied?
It is studied using in vitro enzyme assays, ribosome profiling, mass spectrometry, and CRISPR knockout models [1,2,4,7].
What diseases are associated with tRNA dimethylallyltransferase mutations?
Mutations in TRIT1 are linked to Perrault syndrome and mitochondrial translation defects.
What is the difference between MiaA and TRIT1?
MiaA is the bacterial enzyme, while TRIT1 is the human homolog; both catalyze the same reaction but differ in cellular localization and regulation [1,7].
Can tRNA dimethylallyltransferase be targeted for antibiotics?
Yes, because MiaA is essential for bacterial growth, it is a potential target for antimicrobial development.
What is the substrate specificity of tRNA dimethylallyltransferase?
It specifically recognizes tRNAs with adenosine at position 37 and a compatible anticodon stem-loop structure.
How does DMAPP availability affect tRNA modification?
DMAPP is the prenyl donor; its availability from the mevalonate pathway can limit the rate of i6A formation.
What CRISPR models are available for studying tRNA dimethylallyltransferase?
Knockout, point-mutation, knock-in, and overexpression models can be generated in various cell types to study its function [4,7].
Conclusion
tRNA dimethylallyltransferase activity (GO:0052381) is a conserved molecular function that modifies tRNA to enhance translation. Its study has revealed critical roles in bacterial growth, mitochondrial function, and human disease. The enzyme remains an attractive target for antimicrobial and therapeutic development. With advanced CRISPR tools and bioinformatics, researchers can now dissect its mechanisms and physiological impact with unprecedented precision.
References
- 1. Moore JA et al.. 1997. Escherichia coli dimethylallyl diphosphate:tRNA dimethylallyltransferase: a binding mechanism for recombinant enzyme.. Biochemistry 36(3):604-14 PMID: 9012675
- 2. Soderberg T et al.. 2000. Escherichia coli dimethylallyl diphosphate:tRNA dimethylallyltransferase: essential elements for recognition of tRNA substrates within the anticodon stem-loop.. Biochemistry 39(21):6546-53 PMID: 10828971
- 3. Soderberg T et al.. 2001. Escherichia coli dimethylallyl diphosphate:tRNA dimethylallyltransferase: site-directed mutagenesis of highly conserved residues.. Biochemistry 40(6):1734-40 PMID: 11327834
- 4. Crnković A et al.. 2018. Effects of Heterologous tRNA Modifications on the Production of Proteins Containing Noncanonical Amino Acids.. Bioengineering (Basel) 5(1) PMID: 29393901
- 5. Chen R et al.. 2017. Molecular insights into the enzyme promiscuity of an aromatic prenyltransferase.. Nat Chem Biol 13(2):226-234 PMID: 27992881
- 6. Lamichhane TN et al.. 2011. Plasticity and diversity of tRNA anticodon determinants of substrate recognition by eukaryotic A37 isopentenyltransferases.. RNA 17(10):1846-57 PMID: 21873461
- 7. Tucker EJ et al.. 2020. Genomic sequencing highlights the diverse molecular causes of Perrault syndrome: a peroxisomal disorder (PEX6), metabolic disorders (CLPP, GGPS1), and mtDNA maintenance/translation disorders (LARS2, TFAM).. Hum Genet 139(10):1325-1343 PMID: 32399598
- 8. Sherman MM et al.. 1989. Isolation and characterization of isoprene mutants of Escherichia coli.. J Bacteriol 171(7):3619-28 PMID: 2661529
